Efficiency of Biomarker-Driven Clinical Trial Designs

被引：2
|
作者：
Freidlin, Boris [1 ]
Korn, Edward L. [1 ]
机构：
[1] NCI, Biometr Res Program, Div Canc Treatment & Diag, Biostat Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 12期
关键词：
D O I：
10.1200/JCO.23.02581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Ethical Challenges in Biomarker-Driven Drug Development
    Hey, Spencer Phillips
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 23 - 25
  • [32] BIOMARKER-DRIVEN TRIALS IN EARLY DRUG DEVELOPMENT
    Fine, B. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 22 - 22
  • [33] Arguments against the biomarker-driven diagnosis of AD
    Chiu, Helen F. K.
    Brodaty, Henry
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (02) : 177 - 181
  • [34] EFFICIENCY IN CLINICAL-TRIAL DESIGNS
    OMULLANE, DM
    CARIES RESEARCH, 1976, 10 (02) : 145 - 146
  • [35] Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer
    Ducreux, Michel
    Tabernero, Josep
    Grothey, Axel
    Arnold, Dirk
    O'Dwyer, Peter J.
    Gilberg, Frank
    Abbas, Alexander
    Das Thakur, Meghna
    Prizant, Hen
    Irahara, Natsumi
    Tahiri, Anila
    Schmoll, Hans -Joachim
    Van Cutsem, Eric
    de Gramont, Aimery
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 137 - 150
  • [36] Biomarker-driven precision medicine for hepatocellular carcinoma
    Kodama, Takahiro
    Myojin, Yuta
    Hikita, Hayato
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    CANCER SCIENCE, 2022, 113
  • [37] BIOMARKER-DRIVEN PROGRAMS FOR LUNG CANCER SCREENING
    Massion, Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S6 - S6
  • [38] Biomarker-Driven Staging-Are We There Yet?
    Devarakonda, Siddhartha
    Govindan, Ramaswamy
    JAMA NETWORK OPEN, 2019, 2 (12)
  • [39] Biomarker-driven molecular imaging probes in radiotherapy
    Li, Haonan
    Gong, Qiyong
    Luo, Kui
    THERANOSTICS, 2024, 14 (10): : 4127 - 4146
  • [40] Biomarker-Driven Phase Ib Clinical Trial of OPB-111077 in Acute Myeloid Leukemia Increases Overall Response Rates
    Martinez-Lopez, Joaquin
    Montesinos, Pau
    Sanchez, Pilar Martinez
    Gorrochategui, Julian
    Rojas, Jose Luis
    Primo, Daniel
    Bergua, Juan-Miguel
    Ayala, Rosa M. M.
    Calbacho, Maria
    Lopez-Munoz, Nieves
    Acuna, Evelyn
    Perez-Simon, Jose Antonio
    De la Fuente, Adolfo
    De Oteyza, Jaime Perez
    Rodriguez-Veiga, Rebeca
    Boluda, Blanca
    Cano, Isabel
    Ballesteros, Joan
    BLOOD, 2020, 136
12345